发明名称 P2X RECEPTOR INHIBITOR
摘要 As the results of intensive studies of searching for a compound of a novel type inhibiting P2X2/3,3 receptors, it is found out that minodronic acid, which is one of bisphosphonates having an effect of regulating bone resorption, has a favorable effect of inhibiting the P2X2/3,3 receptors and is usable as a preventive or a remedy for various pains. Namely, a P2X2/3,3 receptor inhibitor, in particular, an analgesic which contains minodronic acid or its salt as the active ingredient. The above-described "P2X2/3 and/or P2X3 receptor inhibitor" inhibits the functions of P2X2/3,3 receptors which are known as molecules participating in various pains such as nociceptive pain, inflammatory pain and neurogenic pain. Owing to this effect, it is useful in preventing or treating various pains wherein the P2X2/3,3 receptors participate in pain transmission.
申请公布号 WO2005072746(A1) 申请公布日期 2005.08.11
申请号 WO2005JP01067 申请日期 2005.01.27
申请人 ASTELLAS PHARMA INC.;KAKIMOTO, SHUICHIRO;TAMURA, SEIJI;NAGAKURA, YUKINORI 发明人 KAKIMOTO, SHUICHIRO;TAMURA, SEIJI;NAGAKURA, YUKINORI
分类号 A61K31/663;C07F9/6561 主分类号 A61K31/663
代理机构 代理人
主权项
地址